Perspective Therapeutics CATX
NYSE CATX
$0.86 +0.02 (+2.38%)
At close: Nov 9, 2026 · 4:00 PM EST

Perspective Therapeutics (CATX) Return on Invested Capital [ROIC] (2023)

Updated

Perspective Therapeutics (CATX) recorded Return on Invested Capital [ROIC] of -43.66% in Q4 2023, down 25.07 percentage points from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Return on Invested Capital [ROIC] (2023) Analysis & Trends

For FY2023, Perspective Therapeutics reported Return on Invested Capital [ROIC] of -58.89%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 38.16%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.57%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 24.28%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 2.88%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 24.11%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 15.60%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -6.11%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 12.34%
10 Perspective Therapeutics 104.44 Mn -132.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -43.24%
Sep 30, 2023 -18.29%
Jun 30, 2023 -11.98%
API Access

Perspective Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=CATX&period=max&api_key=YOUR_API_KEY